Tuesday, May 29, 2012

World arthritis therapeutics market to grow 7.2 ... - My Company PR


The new report entitled ?Arthritis Therapeutics Market to 2018 ? Novel Oral JAK Inhibitors and Biologic Disease Modifying Anti-Rheumatic Drugs (DMARD) Will Drive Continued Growth Across Key Indications? forecasts that the global arthritis therapeutics market will grow 7.2% between to 2018, hitting $38 billion.

The rheumatoid arthritis market was $14 billion in 2010. The market revenue is expected to increase to $26.9 billion by 2018 at a CAGR of 8.5%. The osteoarthritis market is expected to show slower growth among the top four indications.

The top 6 companies in the arthritis therapeutics market accounted for a share of 62% in 2010, leaving 38% of the market dominated by generic therapies and smaller players. Despite a significant number of products available on the market, the high value of biologics keeps the market value high.

View the report: ?Arthritis Therapeutics Market to 2018 ? Novel Oral JAK Inhibitors and Biologic Disease Modifying Anti-Rheumatic Drugs (DMARD) Will Drive Continued Growth Across Key Indications?

?

Pharmaceutical-market-research.com is the source for information products concerning the global biotechnology and pharmaceutical industries. Here you can browse and buy thousands of business information studies, market reports and books. The site is powered by Report Buyer.

Other Press Releases from Pharmaceutical-Market-Research.com

> Diabetes diagnosis, treatment and drug delivery market to hit $17.87 billion by 2018
> Protein-based therapy market to hit $ 143.4 Billion by 2015 says new report
> World hepatitis C drugs market to grow 28% to 2015
> Orphan Disease Therapeutics in CNS Market to Grow 17.6% to 2017 Says New Report
> World biosensor market to grow by 9.6% to reach $16.8billion by 2018

View all posts by Pharmaceutical-Market-Research.com ?


This entry was posted in Healthcare, Pharmaceuticals and tagged biosensors. Bookmark the permalink.

dallas cowboys st louis blues rueben randle mike trout ryan broyles jerel worthy alshon jeffery

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.